Shilpa Medicare has successfully completed Phase 3 clinical trials for SMLNUD07 - NorUDCA, a treatment for Nonalcoholic Fatty Liver Disease (NAFLD), demonstrating significant efficacy and patient tolerance; the trial involved 165 patients across India.